scholarly article | Q13442814 |
P356 | DOI | 10.1128/JVI.03235-14 |
P8608 | Fatcat ID | release_iyw7cl5wojc7zhdomwckljsx3i |
P932 | PMC publication ID | 4403421 |
P698 | PubMed publication ID | 25589663 |
P50 | author | George K. Lewis | Q91710020 |
John L Spouge | Q92400517 | ||
Anthony L DeVico | Q114780410 | ||
P2093 | author name string | Mileidy W Gonzalez | |
P2860 | cites work | Structure and immune recognition of trimeric pre-fusion HIV-1 Env. | Q35142291 |
Lineage-specific differences between human and simian immunodeficiency virus regulation of gp120 trimer association and CD4 binding | Q36155019 | ||
HIV transmission | Q36526615 | ||
Exploration of antigenic variation in gp120 from clades A through F of human immunodeficiency virus type 1 by using monoclonal antibodies | Q36638240 | ||
Selection for specific sequences in the external envelope protein of human immunodeficiency virus type 1 upon primary infection | Q36647820 | ||
Vaccine-induced plasma IgA specific for the C1 region of the HIV-1 envelope blocks binding and effector function of IgG. | Q36895518 | ||
Neutralizing IgG at the portal of infection mediates protection against vaginal simian/human immunodeficiency virus challenge | Q37252676 | ||
Low-dose rectal inoculation of rhesus macaques by SIVsmE660 or SIVmac251 recapitulates human mucosal infection by HIV-1. | Q37273086 | ||
Genetic identity, biological phenotype, and evolutionary pathways of transmitted/founder viruses in acute and early HIV-1 infection | Q37273158 | ||
Immunological and virological mechanisms of vaccine-mediated protection against SIV and HIV. | Q37625296 | ||
Interaction with cellular CD4 exposes HIV-1 envelope epitopes targeted by antibody-dependent cell-mediated cytotoxicity | Q37644079 | ||
HIV-1 genomic RNA diversification following sexual and parenteral virus transmission | Q45873185 | ||
Retrieval and on-the-fly alignment of sequence fragments from the HIV database. | Q48679004 | ||
Structural Definition of an Antibody-Dependent Cellular Cytotoxicity Response Implicated in Reduced Risk for HIV-1 Infection | Q27640572 | ||
Structure of HIV-1 gp120 with gp41-interactive region reveals layered envelope architecture and basis of conformational mobility | Q27658989 | ||
Diverse specificity and effector function among human antibodies to HIV-1 envelope glycoprotein epitopes exposed by CD4 binding | Q27675486 | ||
Crystal Structure of a Soluble Cleaved HIV-1 Envelope Trimer | Q27680496 | ||
Cryo-EM Structure of a Fully Glycosylated Soluble Cleaved HIV-1 Envelope Trimer | Q27680497 | ||
MAFFT Multiple Sequence Alignment Software Version 7: Improvements in Performance and Usability | Q27860817 | ||
Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial | Q28137803 | ||
Human immunodeficiency virus type 1 gp120 envelope glycoprotein regions important for association with the gp41 transmembrane glycoprotein | Q28646759 | ||
Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial | Q28972526 | ||
Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease | Q29616432 | ||
Immune-correlates analysis of an HIV-1 vaccine efficacy trial | Q29617377 | ||
Identification and characterization of transmitted and early founder virus envelopes in primary HIV-1 infection | Q29619510 | ||
A modified Bonferroni method for discrete data | Q30620985 | ||
High Multiplicity Infection by HIV-1 in Men Who Have Sex with Men. | Q33582135 | ||
Tetherin antagonism by Vpu protects HIV-infected cells from antibody-dependent cell-mediated cytotoxicity. | Q33674461 | ||
Characterization of human immunodeficiency virus type 1 (HIV-1) envelope variation and neutralizing antibody responses during transmission of HIV-1 subtype B. | Q33780595 | ||
Selection for human immunodeficiency virus type 1 envelope glycosylation variants with shorter V1-V2 loop sequences occurs during transmission of certain genetic subtypes and may impact viral RNA levels | Q33780649 | ||
Topological layers in the HIV-1 gp120 inner domain regulate gp41 interaction and CD4-triggered conformational transitions | Q33789251 | ||
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection | Q33825654 | ||
Epitope target structures of Fc-mediated effector function during HIV-1 acquisition | Q33924272 | ||
Recurrent signature patterns in HIV-1 B clade envelope glycoproteins associated with either early or chronic infections | Q34042642 | ||
Neutralization escape variants of human immunodeficiency virus type 1 are transmitted from mother to infant | Q34301874 | ||
Phenotypic properties of transmitted founder HIV-1 | Q34336058 | ||
HIV Nef and Vpu protect HIV-infected CD4+ T cells from antibody-mediated cell lysis through down-modulation of CD4 and BST2. | Q34402446 | ||
Genetic impact of vaccination on breakthrough HIV-1 sequences from the STEP trial | Q34648825 | ||
Immune escape from HIV-specific antibody-dependent cellular cytotoxicity (ADCC) pressure | Q34937296 | ||
An HIV-1 gp120 envelope human monoclonal antibody that recognizes a C1 conformational epitope mediates potent antibody-dependent cellular cytotoxicity (ADCC) activity and defines a common ADCC epitope in human HIV-1 serum | Q35077677 | ||
P433 | issue | 7 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | HIV | Q15787 |
Simian immunodeficiency virus | Q1890246 | ||
HIV transmission | Q49029021 | ||
P304 | page(s) | 3619-3629 | |
P577 | publication date | 2015-01-14 | |
P1433 | published in | Journal of Virology | Q1251128 |
P1476 | title | Conserved molecular signatures in gp120 are associated with the genetic bottleneck during simian immunodeficiency virus (SIV), SIV-human immunodeficiency virus (SHIV), and HIV type 1 (HIV-1) transmission | |
P478 | volume | 89 |
Q33780980 | Adenovirus prime, Env protein boost vaccine protects against neutralization-resistant SIVsmE660 variants in rhesus monkeys |
Q47548907 | Alterations of HIV-1 envelope phenotype and antibody-mediated neutralization by signal peptide mutations. |
Q40393973 | Characterization of founder viruses in very early SIV rectal transmission |
Q59357154 | Characterization of the Plasmacytoid Dendritic Cell Response to Transmitted/Founder and Nontransmitted Variants of HIV-1 |
Q36288959 | Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" process |
Q36022372 | HIV-1 Genetic Variation Resulting in the Development of New Quasispecies Continues to Be Encountered in the Peripheral Blood of Well-Suppressed Patients |
Q47552258 | High-Resolution Sequencing of Viral Populations During Early SIV Infection Reveals Evolutionary Strategies for Rapid Escape from Emerging Env-Specific Antibody Responses. |
Q37182674 | Human Th17 Cells Lack HIV-Inhibitory RNases and Are Highly Permissive to Productive HIV Infection |
Q37642937 | Partial HIV C2V3 envelope sequence analysis reveals association of coreceptor tropism, envelope glycosylation and viral genotypic variability among Kenyan patients on HAART. |
Q47109778 | Patterns of conserved gp120 epitope presentation on attached HIV-1 virions |
Q40320261 | Reply to correspondence 'Conserved signatures indicate HIV-1 transmission is under strong selection and thus is not a "stochastic" process' by Gonzalez et al., Retrovirology 2017. |
Q49790276 | Signal peptide of HIV envelope protein impacts glycosylation and antigenicity of gp120. |
Q36523998 | Signatures in Simian Immunodeficiency Virus SIVsmE660 Envelope gp120 Are Associated with Mucosal Transmission but Not Vaccination Breakthrough in Rhesus Macaques |
Q30238730 | Survivors Remorse: antibody-mediated protection against HIV-1. |
Q40697873 | The V1 region of gp120 is preferentially selected during SIV/HIV transmission and is indispensable for envelope function and virus infection |
Search more.